Impact of reimbursement systems on patient care – a systematic review of systematic reviews

Impact of reimbursement systems on patient care – a systematic review of systematic reviews

Abstract Background There is not yet sufficient scientific evidence to answer the question of the extent to which different reimbursement systems influence patient care and treatment quality. Due to the asymmetry of information between physicians, health insurers and patients, market-based mechanism...

Bibliografiset tiedot
Päätekijät:	Eva Wagenschieber, Dominik Blunck
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	BMC 2024-03-01
Sarja:	Health Economics Review
Aiheet:	Reimbursement Fee-for-service Pay-for-performance Bundled payment Process Structure
Linkit:	https://doi.org/10.1186/s13561-024-00487-6

Samankaltaisia teoksia

A cost-reducing reimbursement programme? Effects of value-based reimbursement on healthcare costs
Tekijä: Thérèse Eriksson, et al.
Julkaistu: (2024-12-01)

Evolution of healthcare provider payment mechanisms
Tekijä: V. V. Omelyanovskiy, et al.
Julkaistu: (2020-02-01)

Common spine codes are reimbursed 13% less by Medicaid compared to Medicare, ranging from 46% to 160% by state
Tekijä: Adam P. Henderson, BS, et al.
Julkaistu: (2025-03-01)

Configuring Desired Payment Systems in Healthcare with the “Iranian Tar Model”
Tekijä: Masoud Ferdosi, et al.
Julkaistu: (2024-05-01)

Asymmetric Reimbursement and Contingent Fees in Environmental Conflicts: Observable vs. Unobservable Contracts
Tekijä: Sung-Hoon Park, et al.
Julkaistu: (2023-07-01)

The impact of funding models on the integration of Ontario midwives: a qualitative study
Tekijä: Elizabeth K. Darling, et al.
Julkaistu: (2023-10-01)

Reimbursement measures in European countries – findings of a bibliometric literature review
Tekijä: Sabine Vogler, et al.
Julkaistu: (2015-12-01)

Comparing financing models for supplementary healthcare in appendectomy: activity-based costing (fee-for-service) vs. diagnosis related group remuneration (bundled payment) – a systematic review and meta-analysis
Tekijä: André de Arimatéia de Souza Lino, et al.
Julkaistu: (2023-12-01)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
Tekijä: Karolina Badora, et al.
Julkaistu: (2017-01-01)

Equivalent Modes of Reimbursement in Augmented Contests
Tekijä: Chen Cohen, et al.
Julkaistu: (2023-03-01)

Comparison of pay-for-performance (P4P) programs in primary care of selected countries: a comparative study
Tekijä: Sara Jamili, et al.
Julkaistu: (2023-08-01)

What is the role of antineoplastic drug safety in reimbursement decision making?
Tekijä: A. S. Kolbin, et al.
Julkaistu: (2018-11-01)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
Tekijä: Bérengère Macabeo, et al.
Julkaistu: (2023-12-01)

The effect of trans-provincial immediate reimbursement for healthcare expenses on inequity in the utilization of healthcare services for migrants
Tekijä: Mei Zhou, et al.
Julkaistu: (2024-03-01)

The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer
Tekijä: Sarah Sharman Moser, et al.
Julkaistu: (2023-02-01)

THE AUDIT OF EU NON-REIMBURSABLE FUNDS
Tekijä: OCOLIȘANU ANDREEA
Julkaistu: (2019-10-01)

THE PROCEDURE OF REIMBURSEMENT OF THE COSTS INCURRED IN A TRIAL, IN A SUBSEQUENT TRIAL
Tekijä: Georgiana COMAN
Julkaistu: (2022-06-01)

THEORETICAL AND PRACTICAL ASPECTS REGARDING THE ADJUSTMENT AND REIMBURSEMENT OF VALUE ADDED TAX
Tekijä: CIUMAG MARIN, et al.
Julkaistu: (2021-10-01)

The length of price&reimbursement negotiation procedures in Italy in the period 2021-2023 was independent from the price of medicines
Tekijä: Raffaella Cocciolo, et al.
Julkaistu: (2025-01-01)

Trends in Medicare Utilization and Reimbursement for Traumatic Brain Injury: 2003–2021
Tekijä: Sean Inzerillo, et al.
Julkaistu: (2024-10-01)

Drug pricing and reimbursement decision making systems in Mongolia
Tekijä: Gereltuya Dorj, et al.
Julkaistu: (2017-12-01)

Review of Publicly Available State Reimbursement Policies for Removal and Reinsertion of Long-Acting Reversible Contraception
Tekijä: Okoroh EM, et al.
Julkaistu: (2024-11-01)

Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews
Tekijä: Thomas Desmet, et al.
Julkaistu: (2025-01-01)

Utilization of second medical opinions as a function of the payment method
Tekijä: Liora Shmueli, et al.
Julkaistu: (2025-02-01)

Regional Differences in Primary Total Knee Arthroplasty Utilization, Physician Reimbursement, and Patient Characteristics
Tekijä: Vikram S. Gill, BS, et al.
Julkaistu: (2024-08-01)

Reimbursement of care for severe trauma under SwissDRG
Tekijä: Rudolf M Moos, et al.
Julkaistu: (2016-08-01)

The new remuneration system TARPSY in Swiss psychiatric hospitals: effects on length of stay and readmissions?
Tekijä: Urs Hepp, et al.
Julkaistu: (2020-09-01)

Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
Tekijä: Virginia Ronco, et al.
Julkaistu: (2021-12-01)

National Recommendations for Pharmacoeconomic Evaluations Reporting for Reimbursement and Procurement of New Pharmaceutical Applications in Egypt
Tekijä: Mary Gamal, et al.
Julkaistu: (2024-11-01)

Analysing criteria for price and reimbursement of orphan drugs in Spain
Tekijä: Xavier Badia, et al.
Julkaistu: (2019-07-01)

Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel
Tekijä: Claudio Jommi, et al.
Julkaistu: (2024-07-01)

Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
Tekijä: Hajer Dahmani, et al.
Julkaistu: (2023-12-01)

Health technology assessment and reimbursement of pharmaceuticals in Italy
Tekijä: F. V. Gorkavenko, et al.
Julkaistu: (2019-07-01)

Accessibility of immediate reimbursement for cross-provincial healthcare and its influencing factors for rural residents: a nationwide cross-sectional survey
Tekijä: Min-jiang GUO, et al.
Julkaistu: (2022-11-01)

A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
Tekijä: Elizabeth Docteur, et al.
Julkaistu: (2015-12-01)

Impact of an expanded reimbursement policy on utilization of implantable loop recorders in patients with cryptogenic stroke in Korea
Tekijä: Hye Bin Gwag, et al.
Julkaistu: (2024-05-01)

A systematic review on reporting quality of economic evaluations for negotiated glucose-lowering drugs in China national reimbursement drug list
Tekijä: Shi-Yi Bao, et al.
Julkaistu: (2024-05-01)

Consumer behavior change during the biometric payment technology implementation
Tekijä: l. G. Akhmaeva
Julkaistu: (2022-03-01)

Responding to school funding challenges in no-fee and fee-paying schools: Lessons from South African principals
Tekijä: Inbanathan Naicker, et al.
Julkaistu: (2020-11-01)

SOCIAL ACCOUNTING ASPECTS IN THE PREUNIVERSITY LEVEL REIMBURSEMENT OF STUDENTS
Tekijä: CENAR IULIANA
Julkaistu: (2016-12-01)